A Manchester man hospitalised with COVID-19 in the early days of the pandemic is now giving back to the NHS by taking part in research – and is encouraging others to do the same.
Read more
An international team of researchers, including Dr Hannah Durrington, Honorary Consultant at Wythenshawe Hospital, has found that shift workers showed increased risks of asthma.
Read more
Cellular (T-cell) immunity against SARS-CoV-2 is likely to be present within most adults for at least six months after infection, according to research carried out at MFT.
Read more
A lung cancer patient at Wythenshawe Hospital has taken part in a national project led by Manchester researchers, investigating changes in radiotherapy treatments during COVID-19.
Read more
The first UK patient has been treated in new COVID-19 research trialling the impact of an experimental arthritis drug, otilimab, on severe lung disease related to COVID-19.
Read more
Manchester University NHS Foundation Trust’s (MFT) ground-breaking qUEST research, part of the Manchester Lung Health Checks programme, has been named among the top-recruiting cancer studies in Englan
Read more
Manchester doctors have played a leading role in global coronavirus research, which has found the first drug shown to increase survival rates in people hospitalised with COVID-19.
Read more
